A Study of Secukinumab Treatment in Patients With Plaque Psoriasis and Coexisting Non-alcoholic Fatty Liver Disease (NAFLD)

Conditions:   Plaque Psoriasis;   Non-alcoholic Fatty Liver Disease Interventions:   Biological: Investigational Arm - secukinumab;   Biological: Control Arm - placebo Sponsor:   Novartis Pharmaceuticals Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials